Medical Facilities Corporation (TSX:DR)
Canada · Delayed Price · Currency is CAD 16.95
+0.01 (0.06%)
Nov 13, 2026, 4:00 PM EST
Medical Facilities Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 275 | 285 | 365 | 223 | 211 | 291 | |
Market Cap Growth | 3.68% | -21.83% | 63.60% | 5.96% | -27.57% | 32.81% |
Enterprise Value | 280 | 344 | 518 | 400 | 385 | 456 |
Last Close Price | 16.95 | 15.61 | 15.00 | 8.40 | 7.24 | 8.13 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 5.95 | 9.79 | 3.45 | 9.13 | - | 14.83 |
Forward PE | 9.89 | 8.58 | 16.56 | 10.46 | 10.07 | 10.28 |
PS Ratio | 0.78 | 0.82 | 1.03 | 0.50 | 0.37 | 0.58 |
PB Ratio | 1.92 | 2.07 | 1.72 | 1.43 | 1.36 | 1.33 |
P/TBV Ratio | 9.12 | - | 10.49 | - | - | - |
P/FCF Ratio | 4.40 | 5.17 | 3.33 | 2.98 | 3.10 | 3.42 |
P/OCF Ratio | 3.92 | 4.61 | 3.05 | 2.32 | 2.73 | 3.04 |
PEG Ratio | - | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.79 | 0.99 | 1.46 | 0.89 | 0.67 | 0.90 |
EV/EBITDA Ratio | 3.23 | 4.73 | 6.65 | 5.04 | 3.98 | 4.45 |
EV/EBIT Ratio | 4.05 | 5.38 | 7.99 | 6.15 | 4.62 | 5.60 |
EV/FCF Ratio | 4.48 | 6.23 | 4.73 | 5.34 | 5.66 | 5.36 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.44 | 0.59 | 0.50 | 0.99 | 1.25 | 0.81 |
Debt / EBITDA Ratio | 0.88 | 0.94 | 1.15 | 1.65 | 1.73 | 1.55 |
Debt / FCF Ratio | 1.22 | 1.46 | 0.97 | 2.06 | 2.84 | 2.10 |
Net Debt / Equity Ratio | -0.14 | 0.15 | -0.23 | 0.78 | 0.94 | 0.46 |
Net Debt / EBITDA Ratio | -0.31 | 0.29 | -0.64 | 1.55 | 1.51 | 0.99 |
Net Debt / FCF Ratio | -0.39 | 0.38 | -0.45 | 1.64 | 2.15 | 1.19 |
Asset Turnover | 0.94 | 0.82 | 0.70 | 0.93 | 1.03 | 0.88 |
Inventory Turnover | 20.28 | 25.08 | 18.73 | 22.96 | 27.30 | 25.02 |
Quick Ratio | 2.31 | 1.15 | 1.73 | 1.04 | 1.15 | 1.46 |
Current Ratio | 2.55 | 1.79 | 1.86 | 1.24 | 1.37 | 1.69 |
Return on Equity (ROE) | 34.27% | 27.91% | 36.32% | 24.76% | 8.54% | 26.70% |
Return on Assets (ROA) | 11.57% | 9.42% | 8.04% | 8.39% | 9.34% | 8.89% |
Return on Invested Capital (ROIC) | 38.22% | 35.66% | 27.84% | 18.74% | 18.21% | 22.41% |
Return on Capital Employed (ROCE) | 22.80% | 22.90% | 17.50% | 18.10% | 21.20% | 17.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 16.81% | 10.21% | 28.96% | 10.95% | -2.83% | 6.74% |
FCF Yield | 22.73% | 19.35% | 30.03% | 33.52% | 32.31% | 29.25% |
Dividend Yield | 2.12% | 2.25% | 2.19% | 3.55% | 3.96% | 3.08% |
Payout Ratio | 11.63% | 23.95% | 8.30% | 32.81% | - | 44.63% |
Buyback Yield / Dilution | 4.02% | 18.83% | 4.96% | 14.00% | 5.65% | -0.07% |
Total Shareholder Return | 6.14% | 21.09% | 7.15% | 17.55% | 9.62% | 3.01% |